Compare Arko Corp. (ARKO) vs Davita Inc (DVA) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Arko Corp. vs Davita Inc — how do they compare? Arko Corp. trades at $4.39 (market cap $493.06M), while Davita Inc trades at $179.02 (market cap $11.38B). The key difference: Davita Inc is far larger — about 23.1× Arko Corp.'s market cap, and Arko Corp. pays a 2.73% dividend while Davita Inc pays none. Which is the better fit depends on your goals.
| ARKO | DVA | |
|---|---|---|
Market Cap | $493.06M | $11.38B |
Sector | Consumer Cyclical | Health |
52-Week High | $8.64 | $240.96 |
52-Week Low | $3.82 | $103.87 |
Enterprise Value | $2.67B | $24.10B |
Dividend Yield | 2.73% | — |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Arko Corp.
ARKO Corp operates as a holding company. The company, through its subsidiaries, owns and operates convenience stores in the United States. Some of its regional store brands include Stop, Admiral, Apple Market, BreadBox, E-Z Mart, fas mart, Li'l Cricket, and Next Door Store. Its retail store offers hot food service, beverages, cigarettes & other tobacco products, candy, salty snacks, grocery, beer, and general merchandise. ARKO operates in three segments: Retail, Wholesale, and GPM Petroleum. The company derives the majority of its revenue from retail and wholesale distribution of fuel.
Read more on ARKO →About Davita Inc
DaVita is the largest provider of dialysis services in the United States, boasting market share that eclipses 35% when measured by both patients and clinics. The firm operates over 3,100 facilities worldwide, mostly in the U.S., and treats over 240,000 patients globally each year. Government payers dominate U.S. dialysis reimbursement. DaVita receives approximately 69% of U.S. sales at government (primarily Medicare) reimbursement rates, with the remaining 31% coming from commercial insurers. However, while commercial insurers represented only about 10% of the U.S. patients treated, they represent nearly all of the profits generated by DaVita in the U.S. dialysis business.
Read more on DVA →
